BeyondSpring Inc.
General ticker "BYSI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $72.3M (TTM average)
BeyondSpring Inc. follows the US Stock Market performance with the rate: 23.8%.
Estimated limits based on current volatility of 3.6%: low 1.90$, high 2.04$
Factors to consider:
- Total employees count: 25 as of 2016
- Current price 27.1% above estimated high
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.56$, 1.63$]
- 2024-12-30 to 2025-12-30 estimated range: [0.52$, 1.52$]
Financial Metrics affecting the BYSI estimates:
- Positive: with PPE of -1.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -46.03 <= 0.33
- Positive: Inventory ratio change, % of -50 <= -0.75
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.28 > -0.66
Short-term BYSI quotes
Long-term BYSI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.35MM | $0.00MM | $0.00MM |
| Operating Expenses | $38.59MM | $15.08MM | $8.75MM |
| Operating Income | $-37.24MM | $-15.08MM | $-8.75MM |
| Non-Operating Income | $1.12MM | $1.16MM | $-0.01MM |
| Interest Expense | $0.02MM | $0.00MM | $0.00MM |
| R&D Expense | $25.58MM | $7.27MM | $2.64MM |
| Income(Loss) | $-36.12MM | $-13.92MM | $-8.77MM |
| Taxes | $-0.16MM | $0.09MM | $0.10MM |
| Profit(Loss)* | $-33.28MM | $-21.03MM | $-11.12MM |
| Stockholders Equity | $-5.98MM | $-26.80MM | $-32.90MM |
| Assets | $46.22MM | $24.81MM | $34.31MM |
| Operating Cash Flow | $-28.15MM | $-16.47MM | $-16.44MM |
| Capital expenditure | $0.03MM | $0.10MM | $0.22MM |
| Investing Cash Flow | $18.25MM | $-0.10MM | $-12.01MM |
| Financing Cash Flow | $3.43MM | $0.00MM | $26.79MM |
| Earnings Per Share** | $-0.85 | $-0.54 | $-0.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.